Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Burger

Showing results (211-220 of 342) with videos related to

Pageof 35
Sort By:
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of <i>FGFR3</i> Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Urologia Internationalis|August 21, 2014
Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomyAtiqullah Aziz, Michael Rink, Georgios Gakis, et al.
World Journal of Urology|August 12, 2024
Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patientsRoman Mayr, Simon Udo Engelmann, Yushan Yang, et al.
European Urology|July 20, 2015
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
Urologia Internationalis|August 21, 2014
The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Maximilian Burger, et al.
Frontiers in Bioengineering and Biotechnology|April 18, 2015
Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineMikaël M Martino, Sime Brkic, Emmanuela Bovo, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple?Florian Roghmann, Peter J Goebell, Lars Dyrskjøt, et al.
European Urology|March 30, 2022
Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin ImmunotherapyRoman Mayr, Markus Eckstein, Ralph M Wirtz, et al.
Cancer Research|January 21, 2021
Bladder Tumor Subtype Commitment Occurs in Carcinoma <i>In Situ</i> Driven by Key Signaling Pathways Including ECM RemodelingAdrian Wullweber, Reiner Strick, Fabienne Lange, et al.
European Urology|April 23, 2013
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw dataMaximilian Burger, H Barton Grossman, Michael Droller, et al.
Pageof 35

Showing results (211-220 of 342) with videos related to

Sort By:
Pageof 35
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of <i>FGFR3</i> Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Urologia Internationalis|August 21, 2014
Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomyAtiqullah Aziz, Michael Rink, Georgios Gakis, et al.
World Journal of Urology|August 12, 2024
Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patientsRoman Mayr, Simon Udo Engelmann, Yushan Yang, et al.
European Urology|July 20, 2015
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
Urologia Internationalis|August 21, 2014
The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Maximilian Burger, et al.
Frontiers in Bioengineering and Biotechnology|April 18, 2015
Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineMikaël M Martino, Sime Brkic, Emmanuela Bovo, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple?Florian Roghmann, Peter J Goebell, Lars Dyrskjøt, et al.
European Urology|March 30, 2022
Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin ImmunotherapyRoman Mayr, Markus Eckstein, Ralph M Wirtz, et al.
Cancer Research|January 21, 2021
Bladder Tumor Subtype Commitment Occurs in Carcinoma <i>In Situ</i> Driven by Key Signaling Pathways Including ECM RemodelingAdrian Wullweber, Reiner Strick, Fabienne Lange, et al.
European Urology|April 23, 2013
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw dataMaximilian Burger, H Barton Grossman, Michael Droller, et al.
Pageof 35